Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance-Reference-Cited by-同舟云学术

Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance

Published:2022-09-24 Issue:4 Volume:19 Page:1403-1414
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Pichet Binette Alexa¹^ORCID,Janelidze Shorena¹,Cullen Nicholas¹,Dage Jeffrey L.²,Bateman Randall J.³,Zetterberg Henrik⁴⁵⁶⁷⁸,Blennow Kaj⁴⁵,Stomrud Erik¹⁹,Mattsson‐Carlgren Niklas¹¹⁰¹¹,Hansson Oskar¹⁹

Affiliation:

1. Clinical Memory Research Unit Faculty of Medicine Lund University Lund Sweden

2. Department of Neurology Indiana University School of Medicine Indianapolis Indiana USA

3. Department of Neurology Washington University School of Medicine St Louis Missouri USA

4. Department of Psychiatry and Neurochemistry The Sahlgrenska Academy at the University of Gothenburg Mölndal Sweden

5. Clinical Neurochemistry Laboratory Sahlgrenska University Hospital Mölndal Sweden

6. Department of Neurodegenerative Disease UCL Institute of Neurology Queen Square London UK

7. UK Dementia Research Institute at UCL London UK

8. Hong Kong Center for Neurodegenerative Diseases Hong Kong China

9. Memory Clinic Skåne University Hospital Malmö Sweden

10. Department of Neurology Skåne University Hospital Lund University Lund Sweden

11. Wallenberg Center for Molecular Medicine Lund University Lund Sweden

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12787

Reference42 articles.

1. Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status

2. High performance plasma amyloid-β biomarkers for Alzheimer’s disease

3. High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease;International Journal of Molecular Sciences;2024-01-19

2. Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi‐ethnic Washington Heights–Hamilton Heights–Inwood Columbia Aging Project (WHICAP) cohort;Alzheimer's & Dementia;2024-01-06

3. Blood Markers in Relation to a History of Traumatic Brain Injury Across Stages of Cognitive Impairment in a Diverse Cohort;Journal of Alzheimer's Disease;2024-01-02

4. Plasma Biomarker Strategy for Selecting Patients With Alzheimer Disease for Antiamyloid Immunotherapies;JAMA Neurology;2024-01-01

5. Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-01